Results of the Cancer Screening Feasibility Study in China: a Multicentered Randomized Controlled Trial of Lung and Colorectal Cancer Screening

Jiang Li,Ping Hu,Jufang Shi,Yaguang Fan,Jiansong Ren,Hongda Chen,Ni Li,Xianzhen Liao,Yuqin Liu,Lingbin Du,Ning Wu,Wei Tang,Yueming Zhang,Shuangmei Zou,Paul Pinsky,Philip Prorok,Richard Fagerstrom,Martina Taylor,Barnett Kramer,Min Dai,Jie He
DOI: https://doi.org/10.1016/j.jncc.2021.07.006
IF: 202.731
2019-01-01
The Lancet
Abstract:Background: To provide an understanding of important aspects of the participant recruitment and data collec-tion, become aware of any potential problems, and obtain necessary information in order to design a large-scale randomized controlled trial (RCT) for lung cancer and colorectal cancer (CRC) screening in China. Methods: This feasibility study was a multicentered, open-label, pilot randomized trial. A total of 2696 participants who were at high risk of lung cancer were recruited from three screening centers and randomly allocated to arm 1 ( n = 894), annual low-dose computed tomography (LDCT) plus a baseline colonoscopy; arm 2 ( n = 902), biennial LDCT plus annual fecal immunochemical test (FIT) with OC-Sensor (OC-FIT); and arm 3 ( n = 900), annual Insure -FIT plus Septin 9 blood test. Information on randomization, compliance, positivity rate, cancer case detection, and contamination with screening for lung cancer and CRC were collected. Results: Participant characteristics were similar across study arms. The compliance rate of annual LDCT screening in arm 1 was 86.4% (95% CI: 83.9%, 88.5%) at baseline (T0), and 69.0% (95% CI: 65.8%, 72.0%) and 70.7% (95% CI: 67.6%, 73.7%) at the following two rounds (T1 and T2). The compliance rates of biennial LDCT screening in arm 2 were similar to those in arm 1 in the corresponding rounds. The compliance rate was 55.5% (95% CI: 52.2%, 58.8%) for colonoscopy in arm 1, while the compliance rates of OC-FIT, Insure-FIT, and the Septin 9 test in arms 2 and 3 were all approximately 90% at T0, decreasing to 65%-80% at T1 and T2. The positivity rate, cancer case detection rate, and contamination rate of screening for lung cancer and CRC were also reported. Conclusion: In this pilot study, the feasibility of an RCT in China of lung cancer and CRC screening was demon-strated.
What problem does this paper attempt to address?